Psycho-Oncologists address the emotional, psychological, and social challenges that arise from a cancer diagnosis. They support patients in managing the intense feelings of fear, anxiety, depression, and uncertainty that often accompany cancer and its treatment. By offering counseling, therapy, and coping strategies, psycho-oncologists help individuals process their experiences, maintain emotional stability, and improve their overall quality of life.
Psycho-oncologists also work closely with families and caregivers, who often experience significant stress during a loved one’s illness. They collaborate with oncologists, nurses, and palliative care teams to create integrated care plans that address both physical and psychological needs. In addition, they contribute to research on the impact of mental health in cancer outcomes and help design programs aimed at reducing emotional distress in oncology settings. Psycho-oncologists also provide training to healthcare professionals to improve communication with patients facing emotional distress. Their involvement helps reduce treatment-related trauma and improve patient adherence to care. As a result, psycho-oncologists play a key role in ensuring truly patient-centered cancer care. Their presence ensures that emotional healing progresses alongside physical treatment, promoting a more balanced and compassionate approach to cancer care. Their presence ensures that emotional healing progresses alongside physical treatment, promoting a more balanced and compassionate approach to cancer care. By addressing mental health needs, psycho-oncologists help reduce the psychological burden of illness. This holistic support empowers patients to face their cancer journey with greater strength, clarity, and resilience.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China